Temisis
Develops preclinical small-molecule treatments for inflammatory diseases, including psoriasis
Highlights
- New on EvolcAdded 2026-11-14
About Temisis
Temisis Therapeutics is a preclinical biotechnology company developing small-molecule compounds to treat inflammatory diseases. Its programs include TEM-1657, intended for oral and topical use in psoriasis.
The company was founded in December 2017 and is based in Vandœuvre-lès-Nancy, France.
Product: Preclinical small-molecule drug programs for inflammatory diseases, including TEM-1657 for psoriasis.
Jobs at Temisis
More biotech & pharma companies
Terratis
Sterile-insect mosquito control services for French municipalities and other high-traffic public areasYoung companyNew on EvolcThea Open Innovation
Ophthalmology innovation partnerships and investment for startups, researchers and companies developing eye-care treatmentsTheranovir
Develops therapies targeting cancer, obesity-related diseases and viral infections for patients and healthcare marketsNew on EvolcTheravectys
Lentiviral vector vaccine candidates for cancers and chronic infectious diseases, developed with Institut PasteurNew on EvolcTissium
Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical useTranscure Bioservices
Preclinical CRO running humanized and conventional mouse model studies for drug developers in oncology, inflammation and infectious disease
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.